Sinclair IS Pharma Plc (LON:SPH) was upgraded by stock analysts at Investec to a “buy” rating in a report issued on Tuesday, AnalystRatings.Net reports. The firm currently has a GBX 38 ($0.62) target price on the stock. Investec’s price objective suggests a potential upside of 35.71% from the company’s current price. Sinclair IS Pharma Plc […]
Sinclair IS Pharma Plc Upgraded to “Buy” at Investec (SPH) is a post from: Zolmax
The post Sinclair IS Pharma Plc Upgraded to “Buy” at Investec (SPH) appeared first on Zolmax.